Background
==========

Occupational exposure to vanadium pentoxide (V~2~O~5~) has been associated with an increased incidence of chronic obstructive airway disease and a reduction in lung function \[[@B1]\]. V~2~O~5~is the most common commercial form of vanadium and is the primary form found in industrial exposure situations \[[@B2]\]. Occupational exposure to V~2~O~5~occurs during the cleaning of oil-fired boilers and furnaces, during handling of catalysts in chemical plants, and during the refining, processing, and burning of vanadium-rich fossil fuels \[[@B3]\].

We previously reported that V~2~O~5~causes airway disease in rats that is similar to the pathology of asthma and bronchitis in humans \[[@B4]\]. These pathologic changes include mucous cell hyperplasia, increased airway smooth muscle mass, and peribronchiolar fibrosis. Lung fibroblasts are thought to play a major role in V~2~O~5~-induced airway remodeling *in vivo*, as these cells proliferate around airways following injury and deposit collagen which defines the airway fibrotic lesion \[[@B4],[@B5]\].

Vanadium compounds exert cellular stress via inhibition of protein tyrosine phosphatases (PTPs) in cells \[[@B6]\] and through the generation of reactive oxygen species \[[@B7],[@B8]\]. In particular, vanadium compounds have been shown to stimulate release of H~2~O~2~in several pulmonary cell types, including alveolar macrophages \[[@B9]\], human lung epithelial cells \[[@B10]\], and human lung fibroblasts \[[@B11]\]. Vanadium-induced oxidative stress has been reported to increase the phosphorylation of MAP kinases through the epidermal growth factor receptor (EGFR) \[[@B12]\] and stimulate activation of multiple transcription factors including p53 \[[@B13]\], AP-1 \[[@B14]\], NF-κB \[[@B15]\] and STAT-1 \[[@B8]\]. These transcription factors play major roles in cell proliferation, apoptosis, differentiation, and the induction of pro-inflammatory mediators. These cellular responses, in turn, determine the overall pathologic outcomes (e.g., inflammation, fibrosis) that lead to the development of V~2~O~5~-induced bronchitis.

While much is known about signal transduction pathways that are activated by vanadium-induced oxidative stress, much less is know about genes that are regulated by these signaling pathways. In this study, we investigated V~2~O~5~-induced gene expression in cultured normal human lung fibroblasts using microarray analysis in order to gain a better understanding of the genes that mediate the pathogenesis of fibrosis.

Methods
=======

Cell culture and materials
--------------------------

Normal adult human lung fibroblasts (ATCC 16 Lu) were purchased from American Type Culture Collection (Rockville, MD). Fibroblasts were seeded into 175 cm^2^plastic culture flasks and grown to confluence in 10% fetal bovine serum (FBS)/Dulbecco\'s modified Eagle\'s medium (DMEM), then trypsin-liberated, and seeded into 150 mm dishes. Confluent monolayers were rendered quiescent for 24 hrs in serum-free defined medium (SFDM) that consisted of Ham\'s F-12 medium with 0.25% BSA with an insulin/transferrin/selenium supplement. Cells were treated with 10 μg/cm^2^vanadium pentoxide, V~2~O~5~(Aldrich Chemical, Milwaukee, WI) or SFDM and RNA was harvested from the fibroblast cultures at 1, 4, 8, 12 and 24 hrs post-treatment. We previously reported that this dose of V~2~O~5~causes minimal cytotoxicity (\<10% by lactate dehydrogenase assay) and yet induces H~2~O~2~production, activates intracellular signaling pathways (e.g., MAP kinases), and upregulates growth factor production by human lung fibroblasts \[[@B11]\]. RNA from an SFDM control was harvested at each of these time points to normalize the V~2~O~5~treatment at the same corresponding time point. Three replicate arrays were analyzed for SFDM and V~2~O~5~treatment groups at each of the five time points tested.

Microarray hybridizations and data analysis
-------------------------------------------

Human lung fibroblast RNA was isolated using RNeasy columns (Qiagen, Valencia, CA). RNA quality was verified by spectrophotometry and gel electrophoresis using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Probe preparation and hybridization to the microarray was performed in the CIIT Gene Expression Core Facility using standard Affymetrix procedures. Double-stranded cDNA was synthesized from RNA using an oligo-dT24-T7. Biotinylated cRNA was synthesized from an aliquot of the cDNA template using the T7 RNA Transcript Labeling Kit (ENZO Diagnostics, Farmingdale NY). The labeled cRNA was then fragmented, hybridized to Affymetrix Human Genome U133A 2.0 arrays (Affymetrix, Santa Clara, CA), and stained using phycoerythrein-conjugated streptavidin (Molecular Probes, Eugene, OR). Gene expression results have been deposited in the National Center for Biotechnology Information (NCBI) Expression Omnibus database \[[@B16]\](Accession Number GSE5339).

Statistical analysis and data processing
----------------------------------------

The microarray data were preprocessed using RMA with a log base 2 (log~2~) transformation \[[@B17]\]. Statistical analysis of the data was performed in R using the affyImGUI package \[[@B18],[@B19]\]. To identify genes with significant changes in expression following V~2~O~5~exposure, all treatment groups were analyzed using a linear model with contrasts between untreated fibroblasts and V~2~O~5~-exposed fibroblasts at each time point. Genes from all of the five gene lists were combined for the final analysis. Probability values were adjusted for multiple comparisons using a false discovery rate of 5% (FDR = 0.05) \[[@B20]\]. Genes identified as statistically significant were subject to an additional filter by selecting only those genes that exhibited a ≥ 2-fold change from the untreated fibroblasts. Analysis of gene ontology (GO) categories was performed using NIH DAVID \[[@B21]\]. Statistical significance of the GO results was assessed using a hypergeometric test \[[@B21]\]. GO category hierarchy was obtained using AmiGO \[[@B22]\] and used to discard general categories from the DAVID analysis within the first three levels. Data for genes changed more than 2-fold were clustered using Cluster 3.0 \[[@B22]\] and visualized using the Mapletree Software program \[[@B24]\].

Real Time quantitative RT-PCR
-----------------------------

Total RNA from human lung fibroblasts was isolated using the Qiagen RNeasy Miniprep kit (Valencia, CA). One or two micrograms of total RNA was reverse transcribed at 48°C for 30 minutes using Multiscribe Reverse Transcriptase (Applied Biosystems, Foster City, CA) in 1 × RT buffer, 5.5 mM MgCl~2~, 0.5 μM of each dNTP, 2.5 μM of random hexamers, and 0.4 U/μL RNAse inhibitor in a volume of 100 μl. One hundred nanograms of the RT product was amplified using Taqman Gene Expression Assays on the Applied Biosystems 7700 Prism^®^Sequence Detection System (Applied Biosytems, Foster City, CA). The PCR conditions and data analysis were performed according to the manufacturer\'s protocol described in User bulletin no.2, Applied Biosystems Prism 7700 Sequence Detection System. All samples were run in triplicate. Gene expression was measured by the quantitation of cDNA converted from mRNA corresponding to *VEGF*, *CTGF*, *HBEGF*, *IL8*, *CXCL9*, *CXCL10*, *PIPOX*, *OXR1*, *SOD2*, *STAT1*, *GAS1*, and *EGR1*relative to the untreated control groups and normalized to 18S. 18S expression was not significantly changed in the microarrray experiment and therefore served as an appropriate housekeeping gene. Relative quantitation values ($2^{- \Delta\Delta\text{C}_{\text{T}}}$) were expressed as fold-change.

Results
=======

Exposure of human lung fibroblasts to V~2~O~5~resulted in significantly altered expression of over 1400 genes on the Affymetrix Human Genome U133A 2.0 Array. The majority of significantly changed genes were suppressed by V~2~O~5~exposure over the 24 hr time course. Four major temporal patterns of gene expression were identified by hierarchical clustering analysis; progressively induced genes (Fig. [1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}), genes that were induced in a biphasic manner (Fig. [1C](#F1){ref-type="fig"}), progressively suppressed genes (Fig. [1D](#F1){ref-type="fig"}) and early induced, late suppressed genes (Fig. [1E](#F1){ref-type="fig"}). Examples of genes from each of these temporal categories are shown in Fig. [2](#F2){ref-type="fig"}. The cellular localization and functions of selected genes from each of these categories is shown in Table [1](#T1){ref-type="table"}.

![Heatmap showing hierarchical clustering of human lung fibroblast genes significantly induced (RED) or suppressed (GREEN) by V~2~O~5~treatment. Gene expression in response to V~2~O~5~was considered significant if p-value ≤ 0.05 and exhibited ≥ 2-fold change over untreated control. **Left panel**: All genes changed more than 2-fold. **Panels A and B**: Representative clusters of genes progressively induced. **Panel C**: Representative cluster of genes induced in a biphasic manner. **Panel D**: Representative cluster of suppressed genes. **Panel E**: Representative clusters of genes induced early then suppressed late.](1465-9921-8-34-1){#F1}

![Gene expression profiles of selected genes of interest that fit one of four different temporal expression categories. Fold changes in gene expression over the time course of the experiment are shown on a log~2~scale. **A)**Progressively induced genes, **B)**Progressively suppressed genes, **C)**Genes induced early and suppressed late, and **D)**Genes induced in a biphasic manner. The cellular localization and function of each of these genes are shown in Table 1.](1465-9921-8-34-2){#F2}

###### 

Temporal expression categories of selected genes significantly induced or suppressed by V~2~O~5~exposure and their cellular localization and functions (See Fig. 2).

  **Accession\#**^a^                                 **Gene Symbol**   **Gene Name**                                  **Localization**      **Function**
  -------------------------------------------------- ----------------- ---------------------------------------------- --------------------- -----------------------------
  **[Progressively Induced Genes]{.ul}**                                                                                                    
  Hs.25590                                           *STC1*            Stanniocalcin                                  Secreted              Cellular Metabolism
  Hs.448611                                          *PBEF1*           Pre-B Cell Colony Enhancing Factor 1           Secreted              Inflammation
  Hs.78913                                           *CX3CR1*          Chemokine (C-X3-C motif) Receptor 1            Membrane              Inflammation
  Hs.515258                                          *GDF15*           Growth and Differentiation Factor-15           Secreted              Growth Inhibition
  Hs.471221                                          *KLF7*            Kruppel-like factor 7                          Nuclear               Transcriptional Regulation
  Hs.525704                                          *JUN*             V-jun sarcoma virus 17 oncogene                Nuclear               Transcriptional Regulation
                                                                                                                                            
  **[Progressively Suppressed Gene]{.ul}**                                                                                                  
  Hs.65029                                           *GAS1*            Growth Arrest Specific Gene 1                  Nuclear               Growth Arrest and Apoptosis
  Hs.519162                                          *BTG2*            B-Cell Translocation Gene 2                    Nuclear               Growth Arrest
  Hs.255935                                          *BTG1*            B-Cell Translocation Gene 1                    Nuclear               Growth Arrest
  Hs.8375                                            *TRAF4*           TNF Receptor-Associated Factor                 Membrane              Inflammation/Immunity
  Hs. 109225                                         *VCAM1*           Vascular Cell Adhesion Molecule 1              Membrane              Cell Adhesion
  Hs.519909                                          *MARCKS*          Myristolated Alanine-rich C Kinase Substrate   Cytoplasmic           Cell Signaling
                                                                                                                                            
  **[Early Induced I/Late Suppressed Genes]{.ul}**                                                                                          
  Hs.298654                                          *DUSP6*           MAP kinase phosphatase 3                       Cytoplasmic           Cell Signaling
  Hs.532411                                          *LYST*            Lysosomal Trafficking Regulator Gene           Cytoplasmic           Cell Signaling
  Hs.514746                                          *GATA6*           GATA6 Transcription Factor                     Nuclear               Transcriptional Regulation
  Hs.37982                                           *NEDD9*           Neural expressed Develop. down-regulated 9     Membrane              Cell Adhesion
  Hs.502328                                          *CD44*            CD44 molecule (Indian blood group)             Membrane              Cell Signaling
  Hs.59332                                           *SPRED2*          Sprouty-Related EVH Domain-2                   Cytoplasmic           Cell Signaling
                                                                                                                                            
  **[Biphasic Induced Genes]{.ul}**                                                                                                         
  Hs.326035                                          *EGR1*            Early Growth Response-1 Gene                   Cytoplasmic/Nuclear   Transcriptional Regulation
  Hs.534313                                          *EGR3*            Early Growth Response-3 Gene                   Cytoplasmic/Nuclear   Transcriptional Regulation
  Hs.73853                                           *BMP2*            Bone Morphogenic Protein-1                     Secreted              Cell Differentiation
  Hs.591241                                          *CCNT2*           Cyclin T2                                      Nuclear               Cell Cycle Regulation
  Hs.62661                                           *GBP1*            guanylate-binding protein 1, IFN-inducible     Cytoplasmic           Antiviral Activitiy
  Hs.419240                                          *SLC2A3*          Solute Carrier Family 2 (GLUT3)                Membrane              Metabolism

^a^Gene annotat ions are from NCBI <http://www.ncbi.nlm.nih.gov>.

An analysis of the biological processes (gene ontology categories) affected by V~2~O~5~exposure in human lung fibroblasts was performed using the NIH DAVID program \[[@B21]\]. This analysis revealed that certain GO categories were unique to V~2~O~5~-induced genes, including *chemotaxis*, *inflammatory response*, *immune response*, and *cell-cell signaling*(Table [2](#T2){ref-type="table"}). GO categories that were unique to suppressed genes included *ubiquitin cycle*, *cell cycle*, *DNA repair*, *nuclear transport*, and *programmed cell death*. A few categories such as *RNA processing*were common to induced and suppressed genes.

###### 

Functional analysis of genes induced or suppressed by V~2~O~5~in human lung fibroblasts.^a^

  **GO ID**^b^                  **GO Category**                              **Genes**   **%**^c^   **P value**
  ----------------------------- -------------------------------------------- ----------- ---------- -------------
  **[Induced Genes]{.ul}**                                                                          
  0009605                       response to external stimulus                32          8.47       1.43E-05
  0006935                       chemotaxis                                   13          3.44       6.96E-05
  0009611                       response to wounding                         25          6.61       1.81E-04
  0042221                       response to chemical stimulus                23          6.08       2.51 E-04
  0006950                       response to stress                           44          11.64      0.003553
  0006928                       cell motility                                15          3.97       0.005005
  0006396                       RNA processing                               19          5.03       0.005027
  0008380                       RNA splicing                                 11          2.91       0.007903
  0006954                       inflammatory response                        13          3.44       0.011869
  0008284                       positive regulation of cell proliferation    10          2.65       0.013783
  0006955                       immune response                              33          8.73       0.018616
  0007267                       cell-cell signaling                          23          6.08       0.042107
                                                                                                    
  **[Suppressed Genes]{.ul}**                                                                       
  0045449                       regulation of transcription                  298         19.34      3.61 E-25
  0006512                       ubiquitin cycle                              81          5.26       1.16E-10
  0006391                       RNA processing                               72          4.67       6.25E-10
  0007049                       cell cycle                                   113         7.33       4.42E-08
  0006974                       response to DNA damage stimulus              52          3.37       1.13E-07
  0006295                       DNA metabolism                               94          6.10       2.23E-06
  0006281                       DNA repair                                   43          2.79       1.23E-05
  0008380                       RNA splicing                                 33          2.14       2.56E-05
  0007243                       protein kinase cascade                       50          3.24       3.39E-05
  0051301                       cell division                                31          2.01       2.71 E-04
  0051169                       nuclear transport                            23          1.49       6.27E-04
  0016310                       phosphorylation                              88          5.71       8.76E-04
  0019538                       protein metabolism                           311         20.18      0.001149
  0030518                       steroid hormone receptor signaling pathway   13          0.84       0.001328
  0050658                       RNA transport                                12          0.78       0.002917
  0012501                       programmed cell death                        76          4.93       0.003907
  0001558                       regulation of cell growth                    22          1.43       0.004779
  0016568                       chromatin modification                       22          1.43       0.005351
  0007259                       JAK-STAT cascade                             9           0.58       0.008321
  0007050                       cell cycle arrest                            14          0.91       0.013090
  0016055                       Wnt receptor signaling pathway               18          1.17       0.020398
  0015031                       protein transport                            65          4.22       0.034144
  0008286                       insulin receptor signaling pathway           6           0.39       0.039295
  0007249                       l-kappaB kinase/NF-kappaB cascade            18          1.17       0.042224

^a^GO analysis performed using NIH DAVID <http://david.abcc.ncifcrf.gov>.

^b^Gene ontology ID numbers obtained from AmiGO <http://www.genedb.org/amigo/perl/go.cgi>.

^c^% of total induced or suppressed genes.

While analysis of GO biological processes was useful in assessing the overall numbers of significantly changed genes in various functional categories, we selectively grouped genes that have been shown to play important roles in various aspects of tissue injury, repair, and remodeling. These categories included A) *cytokines and chemokines*, B) *growth factors*, C) *STAT signaling*, D) *cell cycle regulation*, E) *oxidative stress*, and F) *TGF-β signaling*(Fig. [3](#F3){ref-type="fig"}). The functions and cellular localization of representative genes from each of these categories is shown in Table [3](#T3){ref-type="table"}. A number of cytokines and chemokines were induced over the time course, including *IL8*, *IL-6*, *CCL8*, *CXCL9*, and *CXCL10*, while *IL15*was suppressed in a time-dependent manner (Fig. [3A](#F3){ref-type="fig"}). *VEGF*, *HGF*, and *HBEGF*were progressively induced, while *FGF2*and *FGF9*were suppressed (Fig. [3B](#F3){ref-type="fig"}). *CTGF*was induced early (4 hrs) and suppressed late. Members of the STAT signaling pathway were differentially regulated (Fig. [3C](#F3){ref-type="fig"}). IRF-1 was induced in a biphasic manner. *SOCS3*was progressively induced over the time course, while *SOCS1*and *IFNGR*were progressively suppressed. Genes encoding cell cycle regulation were mainly suppressed, including *CDKN1B*and *CDKN1C*, which function to inhibit cell cycle progression (Fig. [3D](#F3){ref-type="fig"}). Oxidative stress genes were differentially regulated. In particular, *SOD2*and *PIPOX*, which function in peroxide generation, were progressively induced (Fig. [3E](#F3){ref-type="fig"}). *OXR1*and *OXSR1*, which are protective against oxidative stress, were suppressed. Genes involved in TGF-β signaling and collagen deposition were suppressed, including *TGFB2*, *SMAD1*, *SMURF1*, *COL1A1*, *COL1A2*, and *COL3A1*(Fig. [3F](#F3){ref-type="fig"}).

###### 

Cellular localization and functions of genes regulated by V~2~O~5~grouped by functional categories (See Fig. 3).

  **Accession\#**^a^                    **Gene Symbol**   **Gene Name**                                  **Localization**      **Function**
  ------------------------------------- ----------------- ---------------------------------------------- --------------------- -----------------------------
  **Cytokines and Chemokines**                                                                                                 
  Hs.512234                             *IL6*             lnterleukin-6 (interferon beta2)               Secreted              Inflammation
  Hs.624                                *IL8*             lnterleukin-8                                  Secreted              Neutrophil Chemotaxis
  Hs. 168132                            *IL15*            lnterleukin-15                                 Secreted              T Lymphocyte Proliferation
  Hs.271387                             *CCL8*            CC Chemokine Ligand 8                          Secreted              Neutrophil Chemotaxis
  Hs.77367                              *CXCL9*           Chemokine (C-X-C motif) Ligand 9 (Mig)         Secreted              Inflammation
  Hs.632586                             *CXCL10*          Chemokine (C-X-C motif) Ligand 10 (IP-10)      Secreted              Inflammation
                                                                                                                               
  **Growth Factors**                                                                                                           
  Hs.73793                              *VEGF*            Vascular Endothelial Cell Growth Factor        Secreted              Endothelial Cell Growth
  Hs.396530                             *HGF*             Hepatocyte Growth Factor                       Secreted              Epithelial Cell Growth
  Hs.799                                *HBEGF*           Heparin-Binding EGF-like Growth Factor         Membrane/Secreted     Fibroblast Growth
  Hs.591346                             *CTGF*            Connective Tissue Growth Factor                Secreted              Collagen Synthesis
  Hs.111                                *FGF9*            Fibroblast Growth Factor-9                     Membrane/Secreted     Fibroblast Growth
  Hs.284244                             *FGF2*            Fibroblast Growth Factor-2                     Membrane/Secreted     Fibroblast Growth
                                                                                                                               
  **STAT Signaling**                                                                                                           
  Hs.591081                             *JAK2*            Janus Activated Kinase-2                       Membrane              STAT Phosphorylation
  Hs.436061                             *IRF1*            Interferon-Regulatory Factor-1                 Cytoplasmic/Nuclear   Transcriptional Regulation
  Hs.527973                             *SOCS3*           Suppressor of Cytokine Signaling-3             Cytoplasmic           Cell Signaling
  Hs.50640                              *SOCS1*           Suppressor of Cytokine Signaling-1             Cytoplasmic           Cell Signaling
  Hs.470943                             *STAT1*           Signal Transducer Activator of Transcription   Cytoplasmic           Growth Arrest and Apoptosis
  Hs.520414                             *IFNGR1*          Interferon Gamma Receptor- 1                   Membrane              Cell Signaling
                                                                                                                               
  **Cell Cycle Regulation**                                                                                                    
  Hs.238990                             *CDKN1B*          Cyclin-Dependent Kinase lnhbitior-1B (Kip1)    Nuclear               Cell Cycle Arrest
  Hs. 106070                            *CDKN1C*          Cyclin-Dependent Kinase lnhibitor-1C (Kip2)    Nuclear               Cell Cycle Arrest
  Hs.525324                             *CDKN2C*          Cyclin-Dependent Kinase lnhibitor-2C           Nuclear               Cell Cycle Arrest
  Hs.557646                             *CDK9*            Cyclin-Dependent Kinase-9                      Nuclear               Transcriptional Regulation
  Hs. 184298                            *CDK7*            Cyclin-Dependent Kinase-7                      Nuclear               Transcriptional Regulation
  Hs. 13291                             *CCNG2*           Cyclin G2                                      Nuclear               Cell Cycle Arrest
                                                                                                                               
  **Oxidative Stress**                                                                                                         
  Hs.475970                             *OXSR1*           Oxidative Stress Response 1                    Cytoplasmic           Intracellular Kinase
  Hs.487046                             *SOD2*            Superoxide Dismutase 2 (SOD2)                  Cytoplasmic           Peroxide Generation
  Hs. 148778                            *OXR1*            Oxidative Resistance 1                         Cytoplasmic           Anti-Oxidant
  Hs.462585                             *PIPOX*           Pipecolic Acid Oxidase                         Cytoplasmic           Peroxide Generation
  Hs.465870                             *KEAP1*           Kelch-like ECH-associated protein 1            Cytoplasmic           Redox Homeostasis
  Hs.406515                             *NQO1*            NAD(P)H:quinone oxidoreductase 1               Cytoplasmic           Redox Homeostasis
                                                                                                                               
  **TGF-beta Signaling and Collagen**                                                                                          
  Hs. 133379                            *TGFB2*           Transforming Growth Factor beta-2              Secreted              Matrix Synthesis, Immunity
  Hs.519005                             *SMAD1*           mothers against DPP homolog 1                  Cytoplasmic           Cell Signaling
  Hs. 189329                            *SMURF1*          Smad Ubiquitin Regulatory Factor-1             Cytoplasmic           Cell Signaling
  Hs.489142                             *COL1A2*          Collagen 1A2                                   Secreted              Structural Protein
  Hs. 172928                            *COL1A1*          Collagen 1A1                                   Secreted              Structural Protein
  Hs.443625                             *COL3A1*          Collagen 3A1                                   Secreted              Structural Protein

^a^Gene annotations are from NCBI <http://www.ncbi.nlm.nih.gov>.

![Gene expression profiles of selected genes for six functional categories. Fold changes in gene expression over the time course of the experiment are shown on a log~2~scale. **A)**Cytokines and Chemokines, **B)**Growth Factors, **C)**STAT Signaling, **D)**Cell Cycle Regulation, **E)**Oxidative Stress, and **F)**TGF-β Signaling. The cellular localization and function of each of these genes are shown in Table 3.](1465-9921-8-34-3){#F3}

Taqman quantitative real time RT-PCR was used to validate a dozen selected genes that were induced or suppressed by V~2~O~5~exposure. We chose to validate 3 genes from each of the following categories (*growth factors, chemokines, transcription factors, oxidative stress*) that appear to have important roles in inflammation, repair, or fibrosis. The results obtained with Taqman quantitative RT-PCR closely mirrored the patterns of temporal induction or suppression observed in the microarray experiment (Fig. [4](#F4){ref-type="fig"}).

![Validation of selected genes by Taqman quantitative RT-PCR. RNA was isolated from human lung fibroblasts treated with 10 μg/cm^2^V~2~O~5~at the indicated time points and RT-PCR performed as described in Methods. Three genes from four categories were validated; growth factors (top row: *VEGF*, *HBEGF*, *CTGF*), chemokines (second row: *IL8*, *CXCL9*, *CXCL10*), transcription factors (third row: *Egr1*, *STAT1*, *GAS1*), and oxidative stress genes (bottom row: *PIPOX*, *OXR1*, *SOD2*). The data for each gene was normalized against 18S housekeeping gene and expressed as the mean ratio. Data are representative of at least two replicate experiments and expressed as the mean ± sem of triplicate dishes of cells. The temporal pattern of each V~2~O~5~-altered gene validated by RT-PCR is compared with the result obtained from the microarray experiment (open diamonds).](1465-9921-8-34-4){#F4}

Discussion
==========

Occupational exposure to vanadium oxides has been associated with an increased incidence of obstructive airway disease and a reduction in lung function \[[@B1]\]. In the present study, we investigated the temporal expression of genes in normal human lung fibroblasts exposed V~2~O~5~. We previously reported that 10 μg/cm^2^V~2~O~5~, the same dose used in our microarray experiment, causes minimal cytotoxicity (\<10%) to fibroblasts or epithelial cells over a 24 hr time period \[[@B10],[@B11]\]. This concentration of V~2~O~5~also causes several well-defined phenotypic changes in lung fibroblasts including a marked increase in H~2~O~2~by fibroblasts \[[@B11]\], phosphorylation of the signal transducer and activator of transcription (STAT-1) \[[@B8]\], and increased expression of heparin-binding EGF-like growth factor, HBEGF \[[@B11]\]. Our current study identified genes regulated by V~2~O~5~that could play potentially important roles in oxidative stress, inflammation, growth, and apoptosis during V~2~O~5~-induced lung injury, remodeling and repair. Moreover, our investigation suggests that fibroblasts play an important role in orchestrating the responses of other pulmonary cell types, including neutrophils, airway epithelial cells, lymphocytes, and endothelial cells. The postulated roles of selected genes that were validated by RT-PCR in mediating V~2~O~5~-induced inflammation, repair, and fibrosis are illustrated in Fig. [5](#F5){ref-type="fig"}.

![Illustration showing postulated roles of selected V~2~O~5~-induced or -suppressed genes in the context of upstream cell signaling events and downstream cell responses and pathologic consequences. All genes shown were validated by quantitative RT-PCR (see Fig. 4).](1465-9921-8-34-5){#F5}

A variety of genes encoding cytokines and chemokines were induced or suppressed by V~2~O~5~. For example, V~2~O~5~induced *IL8*and *IL6*, which play important roles in acute inflammation. We validated the strong induction of *IL8*mRNA by RT-PCR. Vanadium rich oil fly ash has been reported to increase *IL8*and *IL6*mRNA and protein expression in normal human airway epithelial cells \[[@B25],[@B26]\]. Moreover, workers exposed to vanadium-rich fuel oil ash have increased IL8 protein in nasal fluid \[[@B27]\]. Chemokines induced by V~2~O~5~could play important roles in the immune response. Notably, V~2~O~5~induced *CXCL9*(*Mig*) and *CXCL10*(inducible protein-10), both of which were validated by RT-PCR. *CXCL9*and *CXCL10*are STAT1-dependent chemokines that function in the recruitment of lymphocytes \[[@B28]\]. We previously showed that V~2~O~5~activates STAT1 in lung fibroblasts \[[@B8]\] and mice deficient in STAT1 are susceptible to pulmonary fibrosis \[[@B29]\]. Moreover, we have observed intratracheal V~2~O~5~exposure in rats causes lymphocytic accumulation surrounding airways and small blood vessels, as well causing proliferation of lymphocytes within the bronchus-associated lymphatic tissue adjacent to large airways \[[@B30]\]. It is possible that STAT1-dependent induction of *CXCL9*and *CXCL10*could be a mechanism for lymphocyte accumulation around airways and blood vessels following lung injury by V~2~O~5~.

Polypeptide growth factors have a variety of functions in airway remodeling that occurs after metal-induced lung injury. Our genomic analysis identified several growth factors that were validated by RT-PCR. Each of these genes had a different temporal pattern of expression. First, vascular endothelial cell growth factor (*VEGF*) was progressively induced after V~2~O~5~treatment. Li and coworkers showed that vanadium induces the expression of *VEGF*in a mouse epithelial cell line through the activation of ERK \[[@B31]\]. *VEGF*promotes angiogenesis by stimulating the proliferation of vascular endothelial cells and fibroblasts \[[@B32]\]. Our data suggest that fibroblasts could function to promote the formation new blood vessels in V~2~O~5~-induced airway fibrotic lesions by signaling endothelial cells via VEGF protein or it is possible that secreted VEGF could stimulate fibroblast replication. Second, *HBEGF*gene expression was increased in a biphasic manner. *HBEGF*functions both in fibroblast mitogenesis and in epithelial repair \[[@B10],[@B11]\]. Third, connective tissue growth factor (*CTGF*) was increased transiently in human lung fibroblasts and then suppressed. We have also reported that V~2~O~5~increases *CTGF*mRNA in the lungs of rats exposed by intratracheal instillation \[[@B30]\]. The temporal differences in the expression of *VEGF*, *HBEGF*, and *CTGF*after V~2~O~5~treatment remain unclear. We have reported that the early induction of *HBEGF*is due to peroxide dependent activation of MAP kinases \[[@B11]\]. We have also observed that V~2~O~5~-induced *CTGF*expression requires MAP kinases (Ingram and Bonner, unpublished observation). The late induction of *HBEGF*and *VEGF*could be due to the delayed induction of a transcriptional regulator gene that is increased in response to V~2~O~5~-induced oxidative stress. One such transcriptional regulator that serves as a master switch for growth factor induction is the early growth response (*EGR1*) gene. *EGR1*was significantly induced at 4 and 24 hr following V~2~O~5~treatment in both microarray and RTPCR experiments. *EGR1*is induced by a variety of factors including cellular stress and functions as a transcriptional regulator to increase the expression of growth factor genes such as *VEGF*\[[@B33]\].

Other growth response genes, including the growth arrest specific (*GAS1*) gene and Bcell translocation genes (*BTG1*and *BTG2*), were progressively suppressed in a time dependent manner after V~2~O~5~exposure. *BTG1*, *BTG2*, and *GAS1*are all anti-mitogenic factors that mediate growth arrest of fibroblasts \[[@B34]-[@B36]\]. Cyclin-dependent kinase inhibitors, *CDKN1B*p27(Kip1) and *CDKN1C*p57(Kip2), were also progressively suppressed. These two kinase inhibitors mediate growth arrest and serve as tumor suppressors \[[@B37],[@B38]\]. Overall, our data suggests that V~2~O~5~stimulates the growth and survival of fibroblasts by suppressing genes encoding anti-mitogenic factors (*GAS1*, *BTG2*, *CDKN1B*, and *CDKN1C*). In particular, our RT-PCR results validated *GAS1*suppression in V~2~O~5~-exposed fibroblasts. While the increased expression of growth factors (i.e., *VEGF*, *HBEGF*, *CTGF*) by fibroblasts exposed to V~2~O~5~is likely important in promoting fibroblast growth and survival, the reduced expression of *GAS1*by V~2~O~5~could be equally important in promoting fibroblast replication and survival. Moreover, V~2~O~5~progressively suppressed *GAS1*over the entire time course of the experiment, indicating sustained loss of growth arrest control when growth factors such as *VEGF*, *HBEGF*, and *CTGF*were maximally induced.

We found that V~2~O~5~induced or suppressed a number of genes that are involved in oxidative stress. Vanadium compounds have been reported to activate several transcription factors and induce the release of inflammatory mediators through the generation of H~2~O~2~\[[@B13],[@B14],[@B8]\]. Also, we previously reported that human lung fibroblasts exposed to V~2~O~5~release micromolar amounts of H~2~O~2~*in vitro*12 to 18 hrs after V~2~O~5~exposure \[[@B11]\]. Two genes encoding peroxide-generating enzymes, *SOD2*and *PIPOX*, were validated by RT-PCR. *SOD2*was progressively increased over the 24 hr time course of V~2~O~5~exposure. *SOD2*serves as a major protective anti-oxidant defense enzyme that converts superoxide anion to H~2~O~2~\[[@B39]\]. V~2~O~5~undergoes redox chemistry to generate superoxide anion, so it is possible that *SOD2*plays a role in reducing V~2~O~5~-induced lung injury. L-pipecolate oxidase (*PIPOX*), a peroxisomal oxidase, was also progressively induced by V~2~O~5~. *PIPOX*utilizes molecular oxygen as a substrate with H~2~O~2~as a product \[[@B40]\]. While V~2~O~5~induces genes that generate peroxide (*SOD2*, *PIPOX*), we also validated suppression of the oxidative resistance gene (*OXR1*). Volkert and colleagues discovered the human *OXR1*gene using a functional genomics approach in a search for genes that function in protection against oxidative damage \[[@B41]\]. While *OXR1*is protective against oxidative stress, the precise function of this gene is not well understood. Because *OXR1*is protective against oxidative injury, suppression of this gene could contribute to V~2~O~5~-induced oxidative stress. Also, the temporal suppression of *OXR1*occurs as *PIPOX*(a pro-oxidative stress gene) is temporally induced.

V~2~O~5~causes airway fibrosis in rats *in vivo*, and it is well known that increased collagen production defines the fibrotic lesion \[[@B4]\]. TGF-β is an essential mediator of collagen production by fibroblasts. Our results showed that *TGFB2*, along with its associated signaling intermediates *SMAD1*and *SMURF1*, were all progressively suppressed by V~2~O~5~. Moreover, several major collagen genes (*COL1A2*, *COL1A1*, *COL3A1*) were suppressed as well. These data indicate that V~2~O~5~does not directly stimulate fibroblasts to deposit collagen. Instead, it is likely that TGF-β or other factors signals produced by neighboring pulmonary cell types to increase collagen production. TGF-β mRNA is increased in the lungs of rats treated with V~2~O~5~. Therefore, during V~2~O~5~-induced fibrogenesis fibroblasts do not appear to be effectors of their own collagen deposition, but likely require other cell types (e.g., macrophages) as a source of TGF-β.

While we used lung fibroblasts in our study, it is highly relevant to consider the effect of V~2~O~5~exposure on gene expression by other lung cell types, including epithelial cells. Li and colleagues used microarray analysis to investigate gene expression changes in human bronchial epithelial cells exposed to vanadium or zinc and identifed a small set of genes that could be used as biomarkers for discriminating vanadium from zinc \[[@B42]\]. They also reported that *IL8*and *PTGS2*(COX-2) were induced several-fold by vanadium but not by zinc. *IL8*and *PTGS2*were also strongly induced in human lung fibroblasts by vanadium in our study. In fact, we previously reported that COX-2 null mice are susceptible to V~2~O~5~-induced lung fibrosis, which emphasized an important protective role for the *PTGS2*gene during fibrogenesis \[[@B43]\].

Conclusion
==========

A variety of genes were induced or suppressed in normal human lung fibroblasts by vanadium pentoxide (V~2~O~5~) that appear to have important functions in inflammation, fibrosis and repair. Our data suggest that both the induction of genes that mediate cell proliferation and chemotaxis (*VEGF*, *CTGF*, *HBEGF*), as well as suppression of genes involved in growth arrest and apoptosis (*GAS1*), is important to the lung fibrotic reaction to V~2~O~5~. The induction of interferon-inducible, STAT1-dependent chemokines (*CXCL9 and CXCL10*) could contribute to both suppression of fibroblast proliferation and lymphocyte accumulation. The strong induction of *IL8*likely contributes to neutrophilic inflammation. An increase in peroxide-generating enzymes (*PIPOX*, *SOD2*) is consistent with H~2~O~2~production by V~2~O~5~, while the reduced expression of protective oxidative response genes (e.g., *OXR1*) could further contribute to oxidative damage. Overall, our study reveals a wide variety of candidate genes that could mediate V~2~O~5~-induced airway remodeling after occupational and environmental exposures.
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